Antisense oligonucleotides useful in treatment of Pompe disease

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11859186
APP PUB NO 20210139913A1
SERIAL NO

17093892

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is directed to antisense oligomeric compounds that may be used in the treatment Pompe disease as well as method for modulating the splicing of the GAA gene and method to treat Pompe disease. Also pharmaceutical compositions comprising the antisense oligomeric compounds are part of the invention.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ERASMUS UNIVERSITY MEDICAL CENTER ROTTERDAMDR MOLEWATERPLEIN 50 ROTTERDAM 3015 GE

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bergsma, Atze Jacobus Rotterdam, NL 7 8
Pijnappel, Wilhelmus Wenceslaus Matthias Rotterdam, NL 12 11
Reuser, Arnoldus Rotterdam, NL 6 8
Van, Der Ploeg Antje Tjitske Rotterdam, NL 11 10
Van, Der Wal Erik Rotterdam, NL 11 10

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Jul 2, 2027
7.5 Year Payment $3600.00 $1800.00 $900.00 Jul 2, 2031
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 2, 2035
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00